ACAndrea CalcagnoMD, DTM&HVideoHIVGulf HIV Clinical Forum 2019Switching ARV Therapy - Clinical and Pharmacological Considerations - Andrea Calcagno, MD, DTM&HView Video
LWLaura WatersMD, FRCPVideoHIVGulf HIV Clinical Forum 2019ARV Toxicity and Their Management (Including Weight Gain) - Laura Waters, MDView Video
RPRoger ParedesMD, PhDVideoHIVGulf HIV Clinical Forum 2019Switching ARV Therapy - Clinical and Resistance Considerations - Roger Paredes, MD, PhDView Video
VideoHIVGulf HIV Clinical Forum 2019Reducing HIV Stigma and Promoting Early Diagnosis - Bandar Alamri, MDView Video
ACAndrea CalcagnoMD, DTM&HVideoHIVGulf HIV Clinical Forum 2019Novel Treatment Options - Long Acting Antiretroviral Compounds - Andrea Calcagno, MD, DTM&HView Video
VideoHIVGulf HIV Clinical Forum 2019Antiretroviral Therapy in Pregnancy: Risks and Benefits - Sanjay Bhagani, BSc, FRCPView Video
CBCharles BoucherMD, PhDVideoHIVGulf HIV Clinical Forum 2019Integrase Inhibitor Resistance: Does it Matter? - Charles Boucher, MD, PhDView Video
VideoHIVEuropean HIV Clinical Forum 2018Novel delivery Systems - What's in the pipeline? | Courtney Fletcher, PharmDView Video
LWLaura WatersMD, FRCPVideoHIVEuropean HIV Clinical Forum 2018Long acting ARV for treatment and prevention - clinical considerations | Laura Waters, MD, FRCPView Video
SWSharon WalmsleyCM, MD, FRCPCVideoHIVEuropean HIV Clinical Forum 2018Integrase Inhibitors in special patient populations | Sharon Walmsley, FRCPC, MD, MSCView Video
PCPedro CahnMD, PhDVideoHIVEuropean HIV Clinical Forum 2018Switch strategies | Pedro Cahn, MD, PhDView Video
JAJosé ArribasMDVideoHIVEuropean HIV Clinical Forum 2018Reduced drug regimens - What are the Data? | José Arribas, MDView Video
